Girard, L.P. 2024. Glucagon-like Peptide Receptor Agonists (GLP-1 receptor agonists): A Powerful Addition to Foundational Therapy Kidney Care in Patients with Type 2 Diabetes Mellitus. Canadian Diabetes & Endocrinology Today. 2, 3 (Nov. 2024), 33–37. DOI:https://doi.org/10.58931/cdet.2024.2333.